DENVER, April 18, 2022 (GLOBE NEWSWIRE) — As the cannabis industry prepares for another anticipated record-breaking sales day on 4/20, multiple factors are aligning to indicate that a surge of new cannabis investors may be preparing to enter the space, according to KEY Investment Partners. “In the early days of the regulated industry, it was primarily […]
By Tiby Erdely, founding partner of KEY Investment Partners There is an uninformed myth that claims the earliest investors in the regulated cannabis industry were all unsophisticated cowboys, or earthy folks that believed cannabis was good for society as well as an untapped source of medical innovations. While this is at least a partially accurate […]
“There is little excitement around the sector,” says Kevin Bush, chief financial officer with Sweet Leaf Madison Capital. “Nonetheless, it is important for investors to keep in mind that all the reasons the sector has been so popular in the past, specifically the unambiguously high growth trajectory of the industry, still exist.” “Curaleaf has developed […]
DENVER, Jan. 11, 2022 /PRNewswire/ — Day Three Labs (DTL), a cannabinoid CPG ingredient manufacturer specializing in the development and commercialization of novel cannabis product solutions, has acquired a patented pharmaceutical-grade cannabinoid infusion technology developed by a leading Israeli bioscience company. The deal was led and structured by KEY Investment Partners with participation from Phyto […]
DENVER, Dec. 20, 2021 /PRNewswire/ — KEY Investment Partners LLC (“KEY”) today announced the closing of its cannabis-focused venture fund (“The Fund”) with approximately $30 million in aggregate capital commitments. KEY Investment Partners provides strategic capital to high-growth companies that are well positioned to develop the infrastructure of the cannabis industry. Leveraging KEY’s extensive network, […]
The MJ Bulls: Raising Cannabis Capital Podcast features public companies, investors and cannabis companies that are raising capital to fund their growth. This year, the Series will feature eighteen of the cannabis industry’s top investors, reviewing the previous 12-months and sharing their 2022 investment strategies. KEY Investment Partners founding partner, Pete Karabas, was featured here […]
ROXBORO, N.C., June 02, 2021 (GLOBE NEWSWIRE) — Open Book Extracts (OBX), a Roxboro, NC-based leading ingredient manufacturer and product development house for the industry’s most innovative and highest quality cannabinoid-enabled products, announced the close of an $11.5M Series B equity financing round through its parent company Steady State. This round of funding, co-led by […]
SAN DIEGO, March 3, 2021 /PRNewswire/ — Rev Ventures Group, a technology driven performance marketing ecosystem, today announced the completion of a $1 million seed round of funding led by KEY Investment Partners with participation from Phyto Partners. The capital will be used to grow Rev Ventures’ management team, expand marketing efforts and develop its portfolio company RevOffers‘ proprietary Attribution Engine. Read […]
BOULDER, Colo., Feb. 10, 2021 (GLOBE NEWSWIRE) — BDSA is pleased to announce Pete Karabas of KEY Investment Partners as chairman of the board as Co-Founder, Roy Bingham, steps down from the chairman role six years after founding the company with fellow Co-Founder, Elisabeth Stahura. Bingham’s dedication and drive helped guide the company to become the premier cannabinoid market […]
There are many shifting sands today – the global pandemic has changed how people conduct business and has created a volatile global economy. At the same time, the US is in the middle of another divided election year that rivals what we saw in 2016. There is a lot to figure out, particularly for those in an emerging, politically charged industry such as cannabis, and the natural question is: what does the global cannabis industry look like going forward?
KEY Investment Partners LLC
1550 Larimer Street, Suite 1084
Denver, Colorado 80202
The information on this website is provided for general informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, any security or investment product. Any such offer or solicitation may be made only by means of definitive offering documents provided to qualified investors. Past performance is not indicative of future results.